XML 41 R29.htm IDEA: XBRL DOCUMENT

Revenues (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of disaggregated revenue

As discussed in Note 1, revenues are recognized under guidance within ASC 606. The following table presents our disaggregated revenue for the periods presented (in thousands):


			For the Years Ended, December 31,
			2022						2021						2020
JAKAFI revenues, net			$	2,409,225					$	2,134,508					$	1,937,850
ICLUSIG revenues, net			105,838						109,395						105,002
PEMAZYRE revenues, net			83,445						68,531						25,884
MINJUVI revenues, net			19,654						4,910						—
OPZELURA revenues, net			128,735						4,668						—
Total product revenues, net			2,746,897						2,322,012						2,068,736
JAKAVI product royalty revenues			331,575						337,991						277,902
OLUMIANT product royalty revenues			134,547						220,875						110,920
TABRECTA product royalty revenues			15,411						10,389						4,144
PEMAZYRE product royalty revenues			1,205						—						—
Total product royalty revenues			482,738						569,255						392,966
Milestone and contract revenues			165,000						95,000						205,000
Total revenues			$	3,394,635					$	2,986,267					$	2,666,702